These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28150698)

  • 1. Gilles de la Tourette syndrome.
    Robertson MM; Eapen V; Singer HS; Martino D; Scharf JM; Paschou P; Roessner V; Woods DW; Hariz M; Mathews CA; Črnčec R; Leckman JF
    Nat Rev Dis Primers; 2017 Feb; 3():16097. PubMed ID: 28150698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gilles de la Tourette syndrome: the current status.
    Robertson MM
    Arch Dis Child Educ Pract Ed; 2012 Oct; 97(5):166-75. PubMed ID: 22440810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Searching for Tourette's syndrome gene. Part 1. Heterogeneity of clinical phenotypes].
    Kowalska A; Midro AT; Janik P; Gogol A; Służewski W; Rajewski A
    Postepy Hig Med Dosw (Online); 2012 Feb; 66():85-8. PubMed ID: 22371410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropsychiatry of Gilles de la Tourette syndrome: The état de l'art.
    Cavanna AE
    Rev Neurol (Paris); 2018 Nov; 174(9):621-627. PubMed ID: 30098800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
    Cavanna AE; David K; Orth M; Robertson MM
    Eur J Paediatr Neurol; 2012 Nov; 16(6):605-12. PubMed ID: 22381812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies.
    Robertson MM
    Lancet Psychiatry; 2015 Jan; 2(1):68-87. PubMed ID: 26359614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gilles de la Tourette syndrome: clinical features of 75 cases from Argentina.
    Micheli F; Gatto M; Gershanik O; Steinschnaider A; Fernandez Pardal M; Massaro M
    Behav Neurol; 1995; 8(2):75-80. PubMed ID: 24487424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional anatomy of Gilles de la Tourette syndrome.
    Ganos C; Roessner V; Münchau A
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1050-62. PubMed ID: 23237884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
    Szejko N; Saramak K; Lombroso A; Müller-Vahl K
    Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood disorders and Gilles de la Tourette's syndrome: An update on prevalence, etiology, comorbidity, clinical associations, and implications.
    Robertson MM
    J Psychosom Res; 2006 Sep; 61(3):349-58. PubMed ID: 16938513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gilles de la Tourette syndrome - A treatable condition?
    Hartmann A; Martino D; Murphy T
    Rev Neurol (Paris); 2016; 172(8-9):446-454. PubMed ID: 27476415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study.
    Rodrigo L; Álvarez N; Fernández-Bustillo E; Salas-Puig J; Huerta M; Hernández-Lahoz C
    Nutrients; 2018 May; 10(5):. PubMed ID: 29735930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gilles de la Tourette syndrome and deep brain stimulation.
    Hariz MI; Robertson MM
    Eur J Neurosci; 2010 Oct; 32(7):1128-34. PubMed ID: 21039952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder.
    Cavanna AE
    CNS Spectr; 2018 Jun; 23(3):213-218. PubMed ID: 29781408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French guidelines for the diagnosis and management of Tourette syndrome.
    Hartmann A; Ansquer S; Brefel-Courbon C; Burbaud P; Castrioto A; Czernecki V; Damier P; Deniau E; Drapier S; Jalenques I; Marechal O; Priou T; Spodenkiewicz M; Thobois S; Roubertie A; Witjas T; Anheim M
    Rev Neurol (Paris); 2024 Oct; 180(8):818-827. PubMed ID: 38760282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychopathological spectrum of Gilles de la Tourette syndrome.
    Cavanna AE; Rickards H
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1008-15. PubMed ID: 23131314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic linkage analysis of Gilles de la Tourette Syndrome in a Colombian family].
    García-Cerén JJ; Valencia-Duarte AV; Cornejo JW; Carrizosa J; Cuartas JM; Zuluaga-Espinosa NA; Bedoya G; Ruiz-Linares A
    Rev Neurol; 2006 Feb 16-28; 42(4):211-6. PubMed ID: 16521059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gilles de la Tourette syndrome: a clinical study on 58 cases].
    Fen CH; Barbosa ER; Miguel EC
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):729-32. PubMed ID: 11593274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.